APAC Cell Sorting Market

APAC Cell Sorting Market Size (2022 to 2027)

The size of the Asia Pacific Cell Sorting Market has been forecasted at USD 35.40 million in 2022. It is forecasted to be growing at a CAGR of 9.5% and worth USD 55.73 million by 2027.

Cell sorting infers the capacity of technology to segregate cells in a sample based on specific parameters, usually on cell properties.

Cell therapies treat a varied range of diseases like cancer and chronic, there has been an increase in research and development activities targeting various cell therapies in the previous decade. The properties on which cell sorting takes place can be extracellular or intracellular, where the former refers to the size, surface protein expression, and morphology, while the latter refers to protein molecule interactions, RNA, and DNA. The development of cell sorting has been an enormously valuable tool in the research efforts taken up in medicine and physiology.

Factors such as rising funding and investments for the development of technologically advanced cell sorters, technological advancements in cell sorters and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is also driven by factors such as the expanding pharmaceutical and biotechnology industries, the growing prevalence of HIV/AIDS and cancer and the launch of specific reagents for specific applications.

However, factors such as the lack of awareness & technical knowledge regarding the use of cell sorters and the high cost of instruments are restraining the growth of this market.

This research report on the APAC Cell Sorting Market has been segmented and sub-segmented into the following categories:

By Technology: 

• FACS-based Droplet Sorting
• MACS
• Microfluidics

By Product: 

• Cell Sorters
• Reagents
• Consumables

By Application: 

• Research
• Clinical

By End User: 

• Research Institutes
• Biopharma Companies
• Medical Schools

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC.

On the basis of region, the Asia Pacific is one of the most lucrative markets for the growth of the cell sorting market and is projected to grow the highest during the forecast period. Factors such as growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region. The Asia-Pacific market has a share of 16% of the entire market and rising at a CAGR of 9.5%.

Some of the notable companies dominating the Asia Pacific Cell Sorting Market Profiled in the Report are Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sony Biotechnology, Inc. (U.S.), Sysmex Partec GmbH (Japan), Cytonome/ST, LLC (U.S.), On-Chip Biotechnologies Co., Ltd. (Japan), and Union Biometrica, Inc. (U.S.).